Clinical application of artificial liver and blood purification: expert consensus recommendations
Yu Chen, Zuo Weize, Jing Chen(Tulane University), 董育玮, Zhongping Duan(Capital Medical University), Lei Wang(Anhui Normal University), Xiaoping Wu(Nanchang University), Tao Han(Tianjin Medical University), Feng Ye(Fujian Medical University), Yan Huang(Fudan University), Yuexin Zhang(University of Houston), Xinmin Zhou, Ying Li(Wuhan National Laboratory for Optoelectronics), Jihong An, Qinghua Lu(Inner Mongolia University of Science and Technology), Xiaobing Gong, Bai Han(Nankai University), Zheng Xin, Li Wu, Li Jun, Gao Yi, Li Hai, Haiying Lu(Shanghai University of Traditional Chinese Medicine), Lu Gaofeng, Shu Li(New York State Department of Health), Sheng Huiping, Luo Xinhua, Ding Yang, Mao Xiaorong, Geng Jiawei, Zou Huaibin, Cheng Jilin, Jin Qinglong, Huang Yuan, Fei Dai, Huo Xiaolin, Na Fu(Jilin University)
Cited by 24
Related Papers
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults
|Annals of Internal Medicine|2004|1.4k
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
|Kidney International|2013|333
The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways
|Nature Communications|2017|250
Comparative analysis of cell lineage differentiation during hepatogenesis in humans and mice at the single-cell transcriptome level
|Cell Research|2020|136
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118